Trinity Biotech ADR buy StockNews.com
Start price
28.08.23
/
50%
€0.70
Target price
28.08.24
-
Performance (%)
-38.57%
End price
02:15
-
Summary
This prediction is currently being closed. Massive losses of -38.57% have been the result for the BUY prediction by StockNews_com. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | 1.743% | 1.903% | 18.038% |
iShares Nasdaq 100 | -2.088% | -0.640% | 25.594% |
iShares Nikkei 225® | 1.306% | 4.161% | 16.556% |
iShares S&P 500 | -0.093% | 0.169% | 24.312% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten